Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population. (OBIMPACOV)

The population suffering from obesity is particularly at risk during this pandemic period. The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or obese.

Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.

Study Overview

• Status: Completed
• Conditions: Obesity; Covid19
• Intervention / Treatment: Other: Questionnaire; Other: Interview

Detailed Description

This is a prospective multicentre study. Participating patients will be recruited from the Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a questionnaire and take part in an interview (a varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).

The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.

• Study Type: Observational
• Enrollment (Actual): 279

Contacts and Locations

Study Locations

• France
  • Limoges, France, 87042
    • CHU de Limoges
  • Pessac, France, 33604
    • Hôpital Haut-Lévêque
  • Poitiers, France, 86000
    • CHU De Poitiers

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

The obese population is the target population of the study.

Description

Inclusion Criteria:

• Patients 18 years of age.
• Be registered in an active file of the 3 partner CSOs.

Exclusion Criteria:

• Patients under 18 years of age.

• Patients under protective measures or deprived of liberty:

  • pregnant or breastfeeding woman,
  • under guardianship,
  • under guardianship,
  • safeguard of justice,
  • incarcerated.

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patient; Participating patients will be recruited from the Specialised Obesity Centres =CSO (CHU and Follow-up and rehabilitation care (SSR), as well as patient associations) to fill in a questionnaire and take part in an interview (varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).	Other: Questionnaire; Questionnaire with 4 axes: sociological, reflexive medical, prospective medical, transversal; Other: Interview; Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.
Professional; Medical and paramedical staff involved in the partner CSOs will also be asked to participate in a semi-structured interview.	Other: Interview; Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Analysed social and psychological impacts of containment	Thanks to sociology questionnaire based on the experience and paths of individuals (not a score). The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.	9 months after inclusion day
Consequences of social distancing during the containment	Thanks to sociology questionnaire based on the experience and paths of individuals(not a score). The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.	9 months after inclusion day

Collaborators and Investigators

• Sponsor: University Hospital, Bordeaux
• Collaborators: Région Nouvelle Aquitaine
• Investigators: Study Chair: Arnaud ALESSANDRIN, Dr, Université de Bordeaux

Study record dates

Study Major Dates

• Study Start (Actual): January 21, 2022
• Primary Completion (Actual): July 28, 2023
• Study Completion (Actual): July 28, 2023

Study Registration Dates

• First Submitted: April 16, 2021
• First Submitted That Met QC Criteria: June 1, 2021
• First Posted (Actual): June 2, 2021

Study Record Updates

• Last Update Posted (Estimated): January 1, 2024
• Last Update Submitted That Met QC Criteria: December 29, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Keywords: Obesity; COVID19; semi-directive interview
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: CHUBX 2020/38

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No